State Street Corp In8 Bio, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in In8 Bio, Inc. stock. As of the latest transaction made, State Street Corp holds 59,246 shares of INAB stock, worth $50,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59,246
Previous 59,246
-0.0%
Holding current value
$50,359
Previous $81,000
14.81%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding INAB
# of Institutions
33Shares Held
8.64MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.87MShares$2.44 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$1.21 Million0.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$950,5260.0% of portfolio
-
683 Capital Management, LLC New York, NY615KShares$522,5400.06% of portfolio
-
Sigma Planning Corp Ann Arbor, MI515KShares$437,8180.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $20.8M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...